STOCKSCOPE

Infratil (ASX: IFT) Delivers 28% Earnings Growth as Data Centre Expansion Unlocks Bigger Opportunities

Danny Aad

Danny Aad

Technology & Biotechnology Specialist | StockScope

Published:3d ago
Infratil (ASX: IFT) Delivers 28% Earnings Growth as Data Centre Expansion Unlocks Bigger Opportunities

Infratil Limited (ASX: IFT) is strengthening its position in digital infrastructure after delivering 28% growth in first-half operating earnings and upgrading its full-year outlook.

The latest results, released on 18 November 2026, highlight accelerating demand for data centres, expanding renewable energy operations and a growing portfolio of strategic infrastructure assets.

With its data centre business, CDC, securing substantial new contracts, the key question is how much additional earnings this expansion could generate over the coming years.

Key Numbers

  • NZ$711 million: HY27 proportionate operational EBITDAF, up 28% from NZ$555 million.
  • NZ$22.3 billion: Portfolio asset value at 30 September 2026, up 8% since March.
  • A$339 million: CDC first-half EBITDAF, increasing 84% from A$184 million.
  • NZ$4.15 billion to NZ$4.45 billion: Updated FY27 proportionate capital expenditure guidance.
  • NZ$1.37 billion to NZ$1.44 billion: Upgraded FY27 proportionate operational EBITDAF guidance.

Data Centre Growth Creates a Major Earnings Opportunity

CDC continues to emerge as one of Infratil's most important growth engines.

During the September half, the business secured 625 megawatts (MW) of additional contracted data centre capacity, lifting its total contracted portfolio to approximately 1.1 gigawatts (GW).

At 30 September, 350MW of capacity was generating revenue, while another 810MW was under construction.

Management expects the fully deployed contracted portfolio to generate approximately A$2.2 billion in annualised EBITDAF by the end of FY29.

This creates a substantial opportunity for earnings growth as contracted developments become operational.

Importantly, CDC benefits from a Baa2 credit rating, with investment-grade counterparties accounting for more than 90% of revenue.

We see these customer relationships, combined with access to development sites, electricity infrastructure and financing, as meaningful competitive strengths in a rapidly expanding industry.

What Stands Out to Us

Infratil's results demonstrate the benefits of building a diversified infrastructure portfolio with exposure to long-term structural growth.

First-half proportionate capital expenditure increased 98% to NZ$2.1 billion, reflecting substantial development activity.

Full-year capital expenditure guidance now stands at NZ$4.15 billion to NZ$4.45 billion.

While this spending represents a significant financial commitment, much of it is directed towards expanding assets with contracted demand and potential recurring earnings.

The company also reported a NZ$248 million net parent loss, partly reflecting a NZ$256 million accounting provision associated with CDC incentive fees.

This accounting result contrasts with the improvement in underlying operational EBITDAF and does not, by itself, indicate declining operating performance.

Nevertheless, converting earnings growth into sustainable free cash flow remains important.

Infratil reported approximately NZ$1.4 billion in available liquidity at 30 September, providing financial flexibility as development activity continues.

What Infratil Is Doing Now

Beyond data centres, Infratil is expanding its renewable energy exposure through Longroad Energy.

Longroad's operating capacity reached 4.2GW, while first-half EBITDAF increased 10% to US$91 million.

One New Zealand also delivered NZ$325 million in EBITDAF, up 10%, contributing established telecommunications earnings.

Meanwhile, Infratil is progressing its Qscan divestment process, potentially allowing greater capital allocation towards its highest-growth infrastructure opportunities.

The company is also exploring integrated energy and digital infrastructure developments, including a proposed 250MW data centre in Stratford, New Zealand, alongside Contact Energy.

These initiatives could strengthen Infratil's ability to support growing data centre electricity requirements.

Insight: Could Infratil's Data Centre Expansion Unlock Greater Portfolio Value?

We think Infratil's latest results reinforce the quality of its infrastructure portfolio and the scale of its longer-term earnings opportunity. CDC's contracted capacity provides a credible foundation for future growth, while renewable energy and telecommunications operations add diversification. Its reported net portfolio asset value of NZ$17.94 per share, up 10% since March, also reflects improving underlying asset valuations. Although substantial capital expenditure and financing requirements remain important considerations, we view Infratil's contracted development pipeline and established operating businesses as compelling strengths. Successful project delivery could support further earnings growth and portfolio value creation.

What Happens Next?

CDC's progress towards its FY28 EBITDAF target exceeding A$1 billion will be an important milestone.

The conversion of contracted capacity into operational data centres, alongside continued renewable energy development, could materially expand Infratil's recurring earnings base.

Construction costs, financing requirements and project delivery schedules will remain important measures of execution.

With stronger operating earnings, upgraded guidance and a substantial contracted development pipeline, Infratil appears well positioned to benefit from growing demand for digital infrastructure and renewable energy.

The next phase will determine how effectively that growth translates into sustainable cash generation and long-term shareholder value.

Danny Aad

Danny Aad

(Technology & Biotechnology Specialist | StockScope)

Danny Aad is an experienced technology executive with a distinguished career spanning more than three decades, including senior leadership positions as Chief Technology Officer (CTO) across the technology and biotechnology sectors. With extensive expertise in technology strategy, digital innovation and the evolving biotechnology landscape, Danny brings a wealth of industry knowledge and technical insight to his analysis of emerging technologies, corporate developments and investment opportunities.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX slides to five-month low as AI sell-off rattles global markets
Market Briefings
Market Briefings

ASX slides to five-month low as AI sell-off rattles global markets

Australian equities: what moved the ASX 200? Australian shares extended their losing streak on Friday, with the S&P/ASX 200 falling 137.8 points, or 1.58%, to close at 8,592.6. This marked...

Mark ElzayedMark Elzayed•
NEXTDC (ASX: NXT) Raises FY27 Earnings Outlook as $140 Million Melbourne Opportunity Remains in Play
Technology
Technology

NEXTDC (ASX: NXT) Raises FY27 Earnings Outlook as $140 Million Melbourne Opportunity Remains in Play

NEXTDC Limited ASX: NXT has delivered an encouraging upgrade to its FY27 earnings guidance, highlighting the strength of its broader data centre business despite electricity supply delays at...

Danny AadDanny Aad•
Trek Metals (ASX: TKM) Hits 40.3% Manganese at Kuro as High-Grade Discovery Opens Up Bigger Potential
Mining
Mining

Trek Metals (ASX: TKM) Hits 40.3% Manganese at Kuro as High-Grade Discovery Opens Up Bigger Potential

A standout 25-metre intersection grading 31.4% manganese has delivered another encouraging result for Trek Metals Limited ASX: TKM, strengthening the exploration potential of its Kuro discov...

Alison ElzayedAlison Elzayed•
EBR Systems (ASX: EBR) Moves Closer to US-Wide Medicare Coverage as Major Growth Opportunity Emerges
Biotech & Health
Biotech & Health

EBR Systems (ASX: EBR) Moves Closer to US-Wide Medicare Coverage as Major Growth Opportunity Emerges

EBR Systems ASX: EBR has taken another significant step towards expanding the commercial reach of its wireless heart pacing technology, with US Medicare authorities proposing national covera...

Danny AadDanny Aad•
Orion Minerals (ASX: ORN) Unlocks US$6.7 Million From Glencore as Major Copper Production Milestone Approaches
Mining
Mining

Orion Minerals (ASX: ORN) Unlocks US$6.7 Million From Glencore as Major Copper Production Milestone Approaches

Orion Minerals ASX: ORN has reached a significant turning point in its copper and zinc development strategy, receiving its first US$6.7 million payment from global mining group Glencore. The...

Alison ElzayedAlison Elzayed•
EMVision Medical Devices (ASX: EMV) Unlocks a 1,700-Hospital Opportunity as Fresh Funding Accelerates Stroke Scanner Development
Biotech & Health
Biotech & Health

EMVision Medical Devices (ASX: EMV) Unlocks a 1,700-Hospital Opportunity as Fresh Funding Accelerates Stroke Scanner Development

EMVision Medical Devices ASX: EMV is building momentum towards a potentially significant commercial breakthrough, with a fresh $306,750 government grant payment supporting the expansion of i...

Danny AadDanny Aad•
Loading more stories...